Great to see some really positive posts, if you really want to get excited check out the American Pharmaceutical Review issue July/ August page 52 53 and 54.
Their Validation approach is winning hearts and saving the industry a lot of time and issues.
I can see a day in the not too distant future when LBT will be flushed with orders and when you consider each sale is worth 1 million over 5 years, the could not only be making a great profit and will be fought after by the big microbiology companies.
100 sales 100 million
keep the positive posts coming it’s a new era
Ann: ASTRAZENECA SALE & SERVICE CONTRACT UP TO A$4.1M, page-62
-
- There are more pages in this discussion • 71 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add LBT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $27.98M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 1252833 | 1.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.6¢ | 1000000 | 1 |
View Market Depth
| Last trade - 09.39am 10/10/2024 (20 minute delay) ? |
| LBT (ASX) Chart |
Day chart unavailable